BindingDB logo
myBDB logout

Patent code US10202411

Compile Data Set for Download or QSAR
Found 20 hits of Enzyme Inhibition Constant Data   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kJ/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
NS3 serine protease (NS3)


(Hepatitis C Virus (Virus))
BDBM347265
PNG
(US10202411, Compound 327)
Show SMILES Nc1nc2n(cnc2c(=O)[nH]1)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](CF)[C@H]1O
Show InChI InChI=1/C11H17FN5O13P3/c12-1-4-5(2-27-32(23,24)30-33(25,26)29-31(20,21)22)28-10(7(4)18)17-3-14-6-8(17)15-11(13)16-9(6)19/h3-5,7,10,18H,1-2H2,(H,23,24)(H,25,26)(H2,20,21,22)(H3,13,15,16,19)/t4-,5-,7-,10-/s2
PDB

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
KEGG
PC cid
PC sid
UniChem
Article
US Patent
n/an/a<250n/an/an/an/an/an/a



IDENIX PHARMACEUTICALS LLC

US Patent


Assay Description
Test compounds in the form of nucleoside triphosphates were examined for inhibitory activity against purified HCV polymerase in a standard assay. Bac...


US Patent US10202411 (2019)


Article DOI: 10.1016/j.bmcl.2005.12.017
BindingDB Entry DOI: 10.7270/Q2RX9F67
More data for this
Ligand-Target Pair
HCV NS5B Mutant(S282T)


(Hepatitis C virus genotype 1b (isolate Japanese) (...)
BDBM347265
PNG
(US10202411, Compound 327)
Show SMILES Nc1nc2n(cnc2c(=O)[nH]1)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](CF)[C@H]1O
Show InChI InChI=1/C11H17FN5O13P3/c12-1-4-5(2-27-32(23,24)30-33(25,26)29-31(20,21)22)28-10(7(4)18)17-3-14-6-8(17)15-11(13)16-9(6)19/h3-5,7,10,18H,1-2H2,(H,23,24)(H,25,26)(H2,20,21,22)(H3,13,15,16,19)/t4-,5-,7-,10-/s2
PDB
MMDB

B.MOAD
GoogleScholar
KEGG
PC cid
PC sid
UniChem
Article
US Patent
n/an/a<250n/an/an/an/an/an/a



IDENIX PHARMACEUTICALS LLC

US Patent


Assay Description
Test compounds in the form of nucleoside triphosphates were examined for inhibitory activity against purified HCV polymerase in a standard assay. Bac...


US Patent US10202411 (2019)


Article DOI: 10.1016/j.bmcl.2005.12.017
BindingDB Entry DOI: 10.7270/Q2RX9F67
More data for this
Ligand-Target Pair
HCV NS5B Mutant(S282T)


(Hepatitis C virus genotype 1b (isolate Japanese) (...)
BDBM347262
PNG
(US10202411, Compound 308)
Show SMILES Nc1nc2n(cnc2c(=O)[nH]1)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](CO)[C@H]1O
Show InChI InChI=1/C11H18N5O14P3/c12-11-14-8-6(9(19)15-11)13-3-16(8)10-7(18)4(1-17)5(28-10)2-27-32(23,24)30-33(25,26)29-31(20,21)22/h3-5,7,10,17-18H,1-2H2,(H,23,24)(H,25,26)(H2,20,21,22)(H3,12,14,15,19)/t4-,5-,7-,10-/s2
PDB
MMDB

B.MOAD
GoogleScholar
KEGG
PC cid
PC sid
UniChem
Article
US Patent
n/an/a<250n/an/an/an/an/an/a



IDENIX PHARMACEUTICALS LLC

US Patent


Assay Description
Test compounds in the form of nucleoside triphosphates were examined for inhibitory activity against purified HCV polymerase in a standard assay. Bac...


US Patent US10202411 (2019)


Article DOI: 10.1016/j.bmcl.2005.12.017
BindingDB Entry DOI: 10.7270/Q2RX9F67
More data for this
Ligand-Target Pair
NS3 serine protease (NS3)


(Hepatitis C Virus (Virus))
BDBM347260
PNG
(US10202411, Compound 305)
Show SMILES OC[C@H]1[C@@H](O)[C@@H](O[C@@H]1COP([O-])(=O)OP([O-])(=O)OP(O)([O-])=O)n1ccc(=O)[nH]c1=O
Show InChI InChI=1/C10H17N2O15P3/c13-3-5-6(4-24-29(20,21)27-30(22,23)26-28(17,18)19)25-9(8(5)15)12-2-1-7(14)11-10(12)16/h1-2,5-6,8-9,13,15H,3-4H2,(H,20,21)(H,22,23)(H,11,14,16)(H2,17,18,19)/p-3/t5-,6-,8-,9-/s2
PDB

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
KEGG
PC cid
PC sid
UniChem
Article
US Patent
n/an/a<250n/an/an/an/an/an/a



IDENIX PHARMACEUTICALS LLC

US Patent


Assay Description
Test compounds in the form of nucleoside triphosphates were examined for inhibitory activity against purified HCV polymerase in a standard assay. Bac...


US Patent US10202411 (2019)


Article DOI: 10.1016/j.bmcl.2005.12.017
BindingDB Entry DOI: 10.7270/Q2RX9F67
More data for this
Ligand-Target Pair
NS3 serine protease (NS3)


(Hepatitis C Virus (Virus))
BDBM347259
PNG
(US10202411, Compound 302)
Show SMILES O[C@@H]1[C@H](CF)[C@@H](COP([O-])(=O)OP([O-])(=O)OP(O)([O-])=O)O[C@H]1n1ccc(=O)[nH]c1=O
Show InChI InChI=1/C10H16FN2O14P3/c11-3-5-6(4-24-29(20,21)27-30(22,23)26-28(17,18)19)25-9(8(5)15)13-2-1-7(14)12-10(13)16/h1-2,5-6,8-9,15H,3-4H2,(H,20,21)(H,22,23)(H,12,14,16)(H2,17,18,19)/p-3/t5-,6-,8-,9-/s2
PDB

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
KEGG
PC cid
PC sid
UniChem
Article
US Patent
n/an/a<250n/an/an/an/an/an/a



IDENIX PHARMACEUTICALS LLC

US Patent


Assay Description
Test compounds in the form of nucleoside triphosphates were examined for inhibitory activity against purified HCV polymerase in a standard assay. Bac...


US Patent US10202411 (2019)


Article DOI: 10.1016/j.bmcl.2005.12.017
BindingDB Entry DOI: 10.7270/Q2RX9F67
More data for this
Ligand-Target Pair
HCV NS5B Mutant(S282T)


(Hepatitis C virus genotype 1b (isolate Japanese) (...)
BDBM347266
PNG
(US10202411, Compound 330)
Show SMILES Nc1nc(N)c2ncn([C@@H]3O[C@H](COP([O-])(=O)OP([O-])(=O)OP(O)([O-])=O)[C@@H](CO)[C@H]3O)c2n1
Show InChI InChI=1/C11H19N6O13P3/c12-8-6-9(16-11(13)15-8)17(3-14-6)10-7(19)4(1-18)5(28-10)2-27-32(23,24)30-33(25,26)29-31(20,21)22/h3-5,7,10,18-19H,1-2H2,(H,23,24)(H,25,26)(H2,20,21,22)(H4,12,13,15,16)/p-3/t4-,5-,7-,10-/s2
PDB
MMDB

B.MOAD
GoogleScholar
KEGG
PC cid
PC sid
UniChem
Article
US Patent
n/an/a<250n/an/an/an/an/an/a



IDENIX PHARMACEUTICALS LLC

US Patent


Assay Description
Test compounds in the form of nucleoside triphosphates were examined for inhibitory activity against purified HCV polymerase in a standard assay. Bac...


US Patent US10202411 (2019)


Article DOI: 10.1016/j.bmcl.2005.12.017
BindingDB Entry DOI: 10.7270/Q2RX9F67
More data for this
Ligand-Target Pair
HCV NS5B Mutant(S282T)


(Hepatitis C virus genotype 1b (isolate Japanese) (...)
BDBM347260
PNG
(US10202411, Compound 305)
Show SMILES OC[C@H]1[C@@H](O)[C@@H](O[C@@H]1COP([O-])(=O)OP([O-])(=O)OP(O)([O-])=O)n1ccc(=O)[nH]c1=O
Show InChI InChI=1/C10H17N2O15P3/c13-3-5-6(4-24-29(20,21)27-30(22,23)26-28(17,18)19)25-9(8(5)15)12-2-1-7(14)11-10(12)16/h1-2,5-6,8-9,13,15H,3-4H2,(H,20,21)(H,22,23)(H,11,14,16)(H2,17,18,19)/p-3/t5-,6-,8-,9-/s2
PDB
MMDB

B.MOAD
GoogleScholar
KEGG
PC cid
PC sid
UniChem
Article
US Patent
n/an/a<250n/an/an/an/an/an/a



IDENIX PHARMACEUTICALS LLC

US Patent


Assay Description
Test compounds in the form of nucleoside triphosphates were examined for inhibitory activity against purified HCV polymerase in a standard assay. Bac...


US Patent US10202411 (2019)


Article DOI: 10.1016/j.bmcl.2005.12.017
BindingDB Entry DOI: 10.7270/Q2RX9F67
More data for this
Ligand-Target Pair
HCV NS5B Mutant(S282T)


(Hepatitis C virus genotype 1b (isolate Japanese) (...)
BDBM347259
PNG
(US10202411, Compound 302)
Show SMILES O[C@@H]1[C@H](CF)[C@@H](COP([O-])(=O)OP([O-])(=O)OP(O)([O-])=O)O[C@H]1n1ccc(=O)[nH]c1=O
Show InChI InChI=1/C10H16FN2O14P3/c11-3-5-6(4-24-29(20,21)27-30(22,23)26-28(17,18)19)25-9(8(5)15)13-2-1-7(14)12-10(13)16/h1-2,5-6,8-9,15H,3-4H2,(H,20,21)(H,22,23)(H,12,14,16)(H2,17,18,19)/p-3/t5-,6-,8-,9-/s2
PDB
MMDB

B.MOAD
GoogleScholar
KEGG
PC cid
PC sid
UniChem
Article
US Patent
n/an/a<250n/an/an/an/an/an/a



IDENIX PHARMACEUTICALS LLC

US Patent


Assay Description
Test compounds in the form of nucleoside triphosphates were examined for inhibitory activity against purified HCV polymerase in a standard assay. Bac...


US Patent US10202411 (2019)


Article DOI: 10.1016/j.bmcl.2005.12.017
BindingDB Entry DOI: 10.7270/Q2RX9F67
More data for this
Ligand-Target Pair
NS3 serine protease (NS3)


(Hepatitis C Virus (Virus))
BDBM347262
PNG
(US10202411, Compound 308)
Show SMILES Nc1nc2n(cnc2c(=O)[nH]1)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](CO)[C@H]1O
Show InChI InChI=1/C11H18N5O14P3/c12-11-14-8-6(9(19)15-11)13-3-16(8)10-7(18)4(1-17)5(28-10)2-27-32(23,24)30-33(25,26)29-31(20,21)22/h3-5,7,10,17-18H,1-2H2,(H,23,24)(H,25,26)(H2,20,21,22)(H3,12,14,15,19)/t4-,5-,7-,10-/s2
PDB

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
KEGG
PC cid
PC sid
UniChem
Article
US Patent
n/an/a<250n/an/an/an/an/an/a



IDENIX PHARMACEUTICALS LLC

US Patent


Assay Description
Test compounds in the form of nucleoside triphosphates were examined for inhibitory activity against purified HCV polymerase in a standard assay. Bac...


US Patent US10202411 (2019)


Article DOI: 10.1016/j.bmcl.2005.12.017
BindingDB Entry DOI: 10.7270/Q2RX9F67
More data for this
Ligand-Target Pair
NS3 serine protease (NS3)


(Hepatitis C Virus (Virus))
BDBM347266
PNG
(US10202411, Compound 330)
Show SMILES Nc1nc(N)c2ncn([C@@H]3O[C@H](COP([O-])(=O)OP([O-])(=O)OP(O)([O-])=O)[C@@H](CO)[C@H]3O)c2n1
Show InChI InChI=1/C11H19N6O13P3/c12-8-6-9(16-11(13)15-8)17(3-14-6)10-7(19)4(1-18)5(28-10)2-27-32(23,24)30-33(25,26)29-31(20,21)22/h3-5,7,10,18-19H,1-2H2,(H,23,24)(H,25,26)(H2,20,21,22)(H4,12,13,15,16)/p-3/t4-,5-,7-,10-/s2
PDB

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
KEGG
PC cid
PC sid
UniChem
Article
US Patent
n/an/a 625n/an/an/an/an/an/a



IDENIX PHARMACEUTICALS LLC

US Patent


Assay Description
Test compounds in the form of nucleoside triphosphates were examined for inhibitory activity against purified HCV polymerase in a standard assay. Bac...


US Patent US10202411 (2019)


Article DOI: 10.1016/j.bmcl.2005.12.017
BindingDB Entry DOI: 10.7270/Q2RX9F67
More data for this
Ligand-Target Pair
NS3 serine protease (NS3)


(Hepatitis C Virus (Virus))
BDBM347268
PNG
(US10202411, Compound 332)
Show SMILES Cc1cn([C@@H]2O[C@H](COP([O-])(=O)OP([O-])(=O)OP(O)([O-])=O)[C@@H](CO)[C@H]2O)c(=O)[nH]c1=O
Show InChI InChI=1/C11H19N2O15P3/c1-5-2-13(11(17)12-9(5)16)10-8(15)6(3-14)7(26-10)4-25-30(21,22)28-31(23,24)27-29(18,19)20/h2,6-8,10,14-15H,3-4H2,1H3,(H,21,22)(H,23,24)(H,12,16,17)(H2,18,19,20)/p-3/t6-,7-,8-,10-/s2
PDB

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
KEGG
PC cid
PC sid
UniChem
Article
US Patent
n/an/a 625n/an/an/an/an/an/a



IDENIX PHARMACEUTICALS LLC

US Patent


Assay Description
Test compounds in the form of nucleoside triphosphates were examined for inhibitory activity against purified HCV polymerase in a standard assay. Bac...


US Patent US10202411 (2019)


Article DOI: 10.1016/j.bmcl.2005.12.017
BindingDB Entry DOI: 10.7270/Q2RX9F67
More data for this
Ligand-Target Pair
NS3 serine protease (NS3)


(Hepatitis C Virus (Virus))
BDBM347261
PNG
(US10202411, Compound 307)
Show SMILES Nc1ncnc2n(cnc12)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](CO)[C@H]1O
Show InChI InChI=1/C11H18N5O13P3/c12-9-7-10(14-3-13-9)16(4-15-7)11-8(18)5(1-17)6(27-11)2-26-31(22,23)29-32(24,25)28-30(19,20)21/h3-6,8,11,17-18H,1-2H2,(H,22,23)(H,24,25)(H2,12,13,14)(H2,19,20,21)/t5-,6-,8-,11-/s2
PDB

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
KEGG
PC cid
PC sid
UniChem
Article
US Patent
n/an/a 625n/an/an/an/an/an/a



IDENIX PHARMACEUTICALS LLC

US Patent


Assay Description
Test compounds in the form of nucleoside triphosphates were examined for inhibitory activity against purified HCV polymerase in a standard assay. Bac...


US Patent US10202411 (2019)


Article DOI: 10.1016/j.bmcl.2005.12.017
BindingDB Entry DOI: 10.7270/Q2RX9F67
More data for this
Ligand-Target Pair
NS3 serine protease (NS3)


(Hepatitis C Virus (Virus))
BDBM347272
PNG
(US10202411, Compound 402)
Show SMILES OC[C@H]1[C@@H](O)[C@@H](O[C@@H]1COP(O)(=O)OP([O-])([O-])=O)n1ccc(=O)[nH]c1=O
Show InChI InChI=1/C10H16N2O12P2/c13-3-5-6(4-22-26(20,21)24-25(17,18)19)23-9(8(5)15)12-2-1-7(14)11-10(12)16/h1-2,5-6,8-9,13,15H,3-4H2,(H,20,21)(H,11,14,16)(H2,17,18,19)/p-2/t5-,6-,8-,9-/s2
PDB

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
KEGG
PC cid
PC sid
UniChem
Article
US Patent
n/an/a 5.50E+3n/an/an/an/an/an/a



IDENIX PHARMACEUTICALS LLC

US Patent


Assay Description
Test compounds in the form of nucleoside triphosphates were examined for inhibitory activity against purified HCV polymerase in a standard assay. Bac...


US Patent US10202411 (2019)


Article DOI: 10.1016/j.bmcl.2005.12.017
BindingDB Entry DOI: 10.7270/Q2RX9F67
More data for this
Ligand-Target Pair
NS3 serine protease (NS3)


(Hepatitis C Virus (Virus))
BDBM347263
PNG
(US10202411, Compound 325)
Show SMILES OC[C@@H]1[C@@H](COP(O)(=O)OP([O-])(=O)OP([O-])([O-])=O)O[C@H]([C@@H]1F)n1ccc(=O)[nH]c1=O
Show InChI InChI=1/C10H16FN2O14P3/c11-8-5(3-14)6(25-9(8)13-2-1-7(15)12-10(13)16)4-24-29(20,21)27-30(22,23)26-28(17,18)19/h1-2,5-6,8-9,14H,3-4H2,(H,20,21)(H,22,23)(H,12,15,16)(H2,17,18,19)/p-3/t5-,6-,8-,9-/s2
PDB

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
KEGG
PC cid
PC sid
UniChem
Article
US Patent
n/an/a 5.50E+3n/an/an/an/an/an/a



IDENIX PHARMACEUTICALS LLC

US Patent


Assay Description
Test compounds in the form of nucleoside triphosphates were examined for inhibitory activity against purified HCV polymerase in a standard assay. Bac...


US Patent US10202411 (2019)


Article DOI: 10.1016/j.bmcl.2005.12.017
BindingDB Entry DOI: 10.7270/Q2RX9F67
More data for this
Ligand-Target Pair
NS3 serine protease (NS3)


(Hepatitis C Virus (Virus))
BDBM347258
PNG
(US10202411, Compound 301)
Show SMILES O[C@H]1[C@@H](O[C@H](COP([O-])(=O)OP([O-])(=O)OP(O)([O-])=O)[C@H]1C(F)F)n1ccc(=O)[nH]c1=O
Show InChI InChI=1/C10H15F2N2O14P3/c11-8(12)6-4(3-25-30(21,22)28-31(23,24)27-29(18,19)20)26-9(7(6)16)14-2-1-5(15)13-10(14)17/h1-2,4,6-9,16H,3H2,(H,21,22)(H,23,24)(H,13,15,17)(H2,18,19,20)/p-3/t4-,6-,7-,9-/s2
PDB

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
KEGG
PC cid
PC sid
UniChem
Article
US Patent
n/an/a 5.50E+3n/an/an/an/an/an/a



IDENIX PHARMACEUTICALS LLC

US Patent


Assay Description
Test compounds in the form of nucleoside triphosphates were examined for inhibitory activity against purified HCV polymerase in a standard assay. Bac...


US Patent US10202411 (2019)


Article DOI: 10.1016/j.bmcl.2005.12.017
BindingDB Entry DOI: 10.7270/Q2RX9F67
More data for this
Ligand-Target Pair
NS3 serine protease (NS3)


(Hepatitis C Virus (Virus))
BDBM347264
PNG
(US10202411, Compound 326)
Show SMILES Nc1ncnc2n(cnc12)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](CF)[C@H]1O
Show InChI InChI=1/C11H17FN5O12P3/c12-1-5-6(2-26-31(22,23)29-32(24,25)28-30(19,20)21)27-11(8(5)18)17-4-16-7-9(13)14-3-15-10(7)17/h3-6,8,11,18H,1-2H2,(H,22,23)(H,24,25)(H2,13,14,15)(H2,19,20,21)/t5-,6-,8-,11-/s2
PDB

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
KEGG
PC cid
PC sid
UniChem
Article
US Patent
n/an/a 5.50E+3n/an/an/an/an/an/a



IDENIX PHARMACEUTICALS LLC

US Patent


Assay Description
Test compounds in the form of nucleoside triphosphates were examined for inhibitory activity against purified HCV polymerase in a standard assay. Bac...


US Patent US10202411 (2019)


Article DOI: 10.1016/j.bmcl.2005.12.017
BindingDB Entry DOI: 10.7270/Q2RX9F67
More data for this
Ligand-Target Pair
NS3 serine protease (NS3)


(Hepatitis C Virus (Virus))
BDBM347269
PNG
(US10202411, Compound 334)
Show SMILES OC[C@H]1C[C@@H](O[C@@H]1COP([O-])(=O)OP([O-])(=O)OP(O)([O-])=O)n1ccc(=O)[nH]c1=O
Show InChI InChI=1/C10H17N2O14P3/c13-4-6-3-9(12-2-1-8(14)11-10(12)15)24-7(6)5-23-28(19,20)26-29(21,22)25-27(16,17)18/h1-2,6-7,9,13H,3-5H2,(H,19,20)(H,21,22)(H,11,14,15)(H2,16,17,18)/p-3/t6-,7-,9-/s2
PDB

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
KEGG
PC cid
PC sid
UniChem
Article
US Patent
n/an/a>1.00E+4n/an/an/an/an/an/a



IDENIX PHARMACEUTICALS LLC

US Patent


Assay Description
Test compounds in the form of nucleoside triphosphates were examined for inhibitory activity against purified HCV polymerase in a standard assay. Bac...


US Patent US10202411 (2019)


Article DOI: 10.1016/j.bmcl.2005.12.017
BindingDB Entry DOI: 10.7270/Q2RX9F67
More data for this
Ligand-Target Pair
NS3 serine protease (NS3)


(Hepatitis C Virus (Virus))
BDBM347271
PNG
(US10202411, Compound 401)
Show SMILES OC[C@H]1[C@@H](O)[C@@H](O[C@@H]1COP(O)([O-])=O)n1ccc(=O)[nH]c1=O
Show InChI InChI=1/C10H15N2O9P/c13-3-5-6(4-20-22(17,18)19)21-9(8(5)15)12-2-1-7(14)11-10(12)16/h1-2,5-6,8-9,13,15H,3-4H2,(H,11,14,16)(H2,17,18,19)/p-1/t5-,6-,8-,9-/s2
PDB

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
Article
US Patent
n/an/a>1.00E+4n/an/an/an/an/an/a



IDENIX PHARMACEUTICALS LLC

US Patent


Assay Description
Test compounds in the form of nucleoside triphosphates were examined for inhibitory activity against purified HCV polymerase in a standard assay. Bac...


US Patent US10202411 (2019)


Article DOI: 10.1016/j.bmcl.2005.12.017
BindingDB Entry DOI: 10.7270/Q2RX9F67
More data for this
Ligand-Target Pair
NS3 serine protease (NS3)


(Hepatitis C Virus (Virus))
BDBM347270
PNG
(US10202411, Compound 335)
Show SMILES Nc1nc2n(cnc2c(=O)[nH]1)[C@H]1C[C@H](CO)[C@@H](COP([O-])(=O)OP([O-])(=O)OP(O)([O-])=O)O1
Show InChI InChI=1/C11H18N5O13P3/c12-11-14-9-8(10(18)15-11)13-4-16(9)7-1-5(2-17)6(27-7)3-26-31(22,23)29-32(24,25)28-30(19,20)21/h4-7,17H,1-3H2,(H,22,23)(H,24,25)(H2,19,20,21)(H3,12,14,15,18)/p-3/t5-,6-,7-/s2
PDB

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
KEGG
PC cid
PC sid
UniChem
Article
US Patent
n/an/a>1.00E+4n/an/an/an/an/an/a



IDENIX PHARMACEUTICALS LLC

US Patent


Assay Description
Test compounds in the form of nucleoside triphosphates were examined for inhibitory activity against purified HCV polymerase in a standard assay. Bac...


US Patent US10202411 (2019)


Article DOI: 10.1016/j.bmcl.2005.12.017
BindingDB Entry DOI: 10.7270/Q2RX9F67
More data for this
Ligand-Target Pair
NS3 serine protease (NS3)


(Hepatitis C Virus (Virus))
BDBM347267
PNG
(US10202411, Compound 331)
Show SMILES Nc1nc2n(nnc2c(=O)[nH]1)[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP(O)([O-])=O)[C@@H](CO)[C@H]1O
Show InChI InChI=1/C10H17N6O14P3/c11-10-12-7-5(8(19)13-10)14-15-16(7)9-6(18)3(1-17)4(28-9)2-27-32(23,24)30-33(25,26)29-31(20,21)22/h3-4,6,9,17-18H,1-2H2,(H,23,24)(H,25,26)(H2,20,21,22)(H3,11,12,13,19)/p-3/t3-,4-,6-,9-/s2
PDB

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
KEGG
PC cid
PC sid
UniChem
Article
US Patent
n/an/a>1.00E+4n/an/an/an/an/an/a



IDENIX PHARMACEUTICALS LLC

US Patent


Assay Description
Test compounds in the form of nucleoside triphosphates were examined for inhibitory activity against purified HCV polymerase in a standard assay. Bac...


US Patent US10202411 (2019)


Article DOI: 10.1016/j.bmcl.2005.12.017
BindingDB Entry DOI: 10.7270/Q2RX9F67
More data for this
Ligand-Target Pair
* indicates data uncertainty>20%